文献库 文献相关信息

题目:
Identification of targetable FGFR gene fusions in diverse cancers.
作者:
Wu(Yi-Mi),Su(Fengyun),Kalyana-Sundaram(Shanker),Khazanov(Nickolay),Ateeq(Bushra),Cao(Xuhong),Lonigro(Robert J),Vats(Pankaj),Wang(Rui),Lin(Su-Fang),Cheng(Ann-Joy),Kunju(Lakshmi P),Siddiqui(Javed),Tomlins(Scott A),Wyngaard(Peter),Sadis(Seth),Roychowdhury(Sameek),Hussain(Maha H),Feng(Felix Y),Zalupski(Mark M),Talpaz(Moshe),Pienta(Kenneth J),Rhodes(Daniel R),Robinson(Dan R),Chinnaiyan(Arul M)
状态:
发布时间2013-06-10 , 更新时间 2016-11-22
期刊:
Cancer Discov
摘要:
Through a prospective clinical sequencing program for advanced cancers, four index cases were identified which harbor gene rearrangements of FGFR2, including patients with cholangiocarcinoma, breast cancer, and prostate cancer. After extending our assessment of FGFR rearrangements across multiple tumor cohorts, we identified additional FGFR fusions with intact kinase domains in lung squamous cell cancer, bladder cancer, thyroid cancer, oral cancer, glioblastoma, and head and neck squamous cell cancer. All FGFR fusion partners tested exhibit oligomerization capability, suggesting a shared mode of kinase activation. Overexpression of FGFR fusion proteins induced cell proliferation. Two bladder cancer cell lines that harbor FGFR3 fusion proteins exhibited enhanced susceptibility to pharmacologic inhibition in vitro and in vivo. Because of the combinatorial possibilities of FGFR family fusion to a variety of oligomerization partners, clinical sequencing efforts, which incorporate transcriptome analysis for gene fusions, are poised to identify rare, targetable FGFR fusions across diverse cancer types.
语言:
eng
DOI:

联系方式

山东省济南市章丘区文博路2号 齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号大学科技园北区F座4单元2楼

电话: 0531-88819269

E-mail: product@genelibs.com

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。